(Q43906314)

27 November 2017

title

Effects of formulation variables on characteristics of poly (ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions (English)

1 reference

27 November 2017

2

1 reference

27 November 2017

Watnasirichaikul S

1

1 reference

27 November 2017

Tucker IG

series ordinal

3

1 reference

27 November 2017

Davies NM

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

International Journal of Pharmaceutics

27 November 2017

published in

1 reference

27 November 2017

volume

235

1 reference

27 November 2017

issue

1-2

1 reference

27 November 2017

page(s)

237-246

1 reference

Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Evaluation of poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery. I. Effect of formulation variables on physicochemical characteristics of nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Polyalkyl cyanoacrylate nanocapsules

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Preparation, characterization and in vitro antimicrobial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Lymphatic Transport of Halofantrine in the Conscious Rat When Administered as Either the Free Base or the Hydrochloride Salt: Effect of Lipid Class and Lipid Vehicle Dispersion

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Molecular weights of free and drug-loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

In vitro heterogeneous degradation of poly(n-alkyl alpha-cyanoacrylates)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900002-9

7 January 2021

10.1016/S0378-5173(02)00002-9

Identifiers

DOI

1 reference

27 November 2017

1 reference